← Back to All Filings

Medtronic Officer Files Form 144 to Sell $138.9K in Common Stock

Low SignificanceSeptember 16, 2026 at 6:38:22 PM UTC

Medtronic plc

$MDT144CIK: 0001613103

Subscribe to track MDT

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Medtronic Officer Files Form 144 to Sell $138.9K in Common Stock

Company: Medtronic plc (MDT) Form: Form 144 | Filed: 2026/09/16 Significance: Low

Insider: Harry Skip Kiil Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale (Form 144) • Shares: 1,483 • Price: ~$93.65 • Value: $138,888.59 • Owned After: N/A

Key Insight: Routine sale of 1,483 shares originating from a restricted stock vesting on July 31, 2026. The transaction represents a negligible fraction (<0.001%) of Medtronic's $119.98B market capitalization.

Comprehensive Analysis

SEC Filing Analysis: Medtronic plc (MDT)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Officer Harry Skip Kiil filed a notice of proposed sale for 1,483 common shares valued at approximately $138.9K.
  • Market Impact: Neutral; transaction size is immaterial relative to Medtronic's $119.98 billion market capitalization.

Company Information

FieldValue
CompanyMedtronic plc
Ticker SymbolMDT
CIK0001613103
IndustryElectromedical & Electrotherapeutic Apparatus

Insider Information

FieldValue
NameHarry Skip Kiil
CIK0001708062
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form TypeForm 144
Transaction Date2026/09/16
Transaction CodeS (Proposed Sale)
Security TypeCommon Stock
Shares Involved1,483
Price Per Share~$93.65
Total Value$138,888.59
Shares Owned AfterN/A
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$138,888.59
% of Market Cap0.0001%
Shares Transacted1,483
% of Shares Outstanding0.0001%
Post-Transaction OwnershipN/A
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap enterprise valued at $119.98 billion, a $138.9K sale is routine and immaterial to liquidity or price action.
  • Dilution / Origin Context: The shares were originally acquired on July 31, 2026, via restricted stock vesting as part of executive equity compensation.
  • Transaction Significance: Low significance given the small absolute amount and negligible fraction of total shares outstanding.

Market Impact Analysis

  • Direction: Neutral
  • Reasoning: Routine liquidation of vested compensation shares with no signaling value regarding operational performance.
  • Expected Volume Impact: Immaterial compared to average daily trading volume.
  • Sentiment Indicator: Neutral

Additional Context

  • Timing: Notice filed on September 16, 2026, for execution through Fidelity Brokerage Services LLC on the NYSE.
  • Special Circumstances: Filer reported no other securities sold during the past three months.
Topics:#SECFiling#Form144#MDT#Medtronic#InsiderTrading#StockAlert#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.